Esnotone Plus Tablet
By Esnotone Plus
Rx
10 Tablet in a Strip

Composition
Guaifenesin(60mg) + Diethylcarbamazine(100mg) + Chlorpheniramine Maleate(2mg)

Manufacturer - Sarmain Pharmaceuticals
22, Bombay Park Society, Opposite Water Tank, Karelibaug, Karelibaug, Vadodara-390018, Gujarat, India

Expires on or after
September, 2026

liver
Esnotone Plus Tablet should be used cautiously in individuals with liver disease. It may be necessary to adjust the dosage of Esnotone Plus Tablet for these patients. It is crucial to consult your doctor before taking this medication if you have a liver condition. There is limited information regarding the use of Esnotone Plus Tablet in individuals with liver issues.

kidney
Esnotone Plus Tablet is generally safe for patients with kidney disease. Data shows dose adjustment may not be required, but consult your doctor. Note Patients with end stage kidney disease may experience increased drowsiness when using Esnotone Plus Tablet.

alcohol
Esnotone Plus Tablet can result in increased drowsiness when combined with alcohol.

driving
Esnotone Plus Tablet can reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Esnotone Plus Tablet may be unsafe during pregnancy, as animal studies have shown harmful effects on the developing baby. Your doctor will assess the benefits and risks before prescribing it. Please consult your doctor.

breastfeeding
It is better to consult your doctor before using Esnotone Plus Tablet.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹17
₹20
15% OFF
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025
